Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations
More topics under "A61P - Specific therapeutic activity of chemical compounds or medicinal preparations" (2,008,710)
A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798)
A61P 11 - Drugs for disorders of the respiratory system (87,767)
A61P 13 - Drugs for disorders of the urinary system (56,135)
A61P 15 - Drugs for genital or sexual disorders; Contraceptives (55,635)
A61P 17 - Drugs for dermatological disorders (106,455)
A61P 19 - Drugs for skeletal disorders (81,981)
A61P 21 - Drugs for disorders of the muscular or neuromuscular system (23,287)
A61P 23 - Anaesthetics (4,141)
A61P 25 - Drugs for disorders of the nervous system (183,225)
A61P 27 - Drugs for disorders of the senses (53,017)
A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169)
A61P 3 - Drugs for disorders of the metabolism (129,789)
A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
A61P 33 - Antiparasitic agents (21,787)
A61P 35 - Antineoplastic agents (221,099)
A61P 37 - Drugs for immunological or allergic disorders (117,141)
A61P 39 - General protective or antinoxious agents (19,019)
A61P 41 - Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution (3,707)
A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
A61P 5 - Drugs for disorders of the endocrine system (28,908)
A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065)
A61P 9 - Drugs for disorders of the cardiovascular system (159,484)
Patents for A61P - Specific therapeutic activity of chemical compounds or medicinal preparations (3,181)
12/2012
12/05/2012CN1893977B Remedies for diseases with bone mass loss having ep4 agonist as the active ingredient.
12/04/2012US8324184 Anti-adhesion composites and methods of use thereof
11/2012
11/29/2012US20120302557 Biologically active methylene blue derivatives
11/28/2012CN102793692A Compounds for inflammation and immune-related uses
11/20/2012US8314104 Method of treating diabetes
11/08/2012US20120283285 Treatment of solid tumors with rapamycin derivatives
11/08/2012US20120282219 Peptidomimetic protease inhibitors
11/06/2012US8304414 Pyrazole compounds useful as protein kinase inhibitors
11/01/2012US20120277258 Chemical Compounds
10/2012
10/16/2012US8287877 Composition comprising immunogenic microparticles
10/04/2012US20120252847 Novel form of s-omeprazole
09/2012
09/19/2012EP1666481B1 3-((3R,4R)-4-Methyl-3-[methyl-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-amino]-piperidinyl)-3-oxo-propionitrile as protein kinase inhibitor
09/18/2012US8268790 Dermatalogical formulations
09/11/2012CA2533598C Method for modulating calcium ion-release-activated calcium ion channels
09/06/2012US20120225031 Sphingosine-1-phosphate receptor agonists in the treatment of demyelinating disorders
08/2012
08/30/2012US20120216802 Composition for inhalation
08/29/2012CN101028519B Pharmaceutical composition for treating immune diseases
08/28/2012US8252923 Peptidomimetic protease inhibitors
08/28/2012US8252818 Nicotinamide derivatives useful as P38 inhibitors
08/28/2012CA2476939C Pharmaceutical combinations of cox-2 inhibitors and opiates
08/23/2012US20120214774 Treatment of solid tumors with rapamycin derivatives
08/14/2012US8242146 Administering ROFLUMILAS and DICLOFENAC; antiinflammatory agents
08/07/2012US8236947 Quinoline derivatives and their use as 5-HT6 ligands
08/01/2012EP1405852B1 Diamine derivatives
07/2012
07/31/2012US8232401 Useful as an anti-HIV agent that particularly shows an anti-HIV action based on an integrase inhibitory activity; for treatment or prophylaxis of AIDS; for example, 6-(2,3-dichlorobenzyl)-1-(2-hydroxyethyl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid
07/25/2012EP1390349B1 Aminoquinoline and aminopyridine derivatives and their use as adenosine a3 ligands
07/24/2012US8227471 Treating sexual desire disorders with flibanserin
07/24/2012CA2412172C 1,2-dihydropyridine compounds, manufacturing method thereof and use thereof
07/11/2012CN102552933A 蛋氨酸酶在抗蛋氨酸和抗高半胱氨酸的化学治疗中的应用 Methioninase used in chemotherapy anti-methionine and homocysteine ​​in the anti-
07/10/2012US8217157 Compositions and methods for treating and preventing heart tissue degeneration, and uses thereof
07/10/2012CA2360003C Tricyclic inhibitors of poly(adp-ribose) polymerases
07/04/2012CN102526079A 治疗脱髓鞘疾病的鞘氨醇-1-磷酸受体激动剂 Treatment of demyelinating diseases of the sphingosine-1-phosphate receptor agonist,
07/04/2012CN101898982B Npy y5 antagonists
06/2012
06/28/2012US20120165348 Novel compounds
06/20/2012CN102504014A Peptidomimetic protease inhibitors
05/2012
05/30/2012EP1178808B1 Non-aqueous pharmaceutical composition for dermal use to treat psoriasis comprising a vitamin d, a corticosteroid and a solvent component
05/30/2012CN101579344B Low hygroscopic aripiprazole drug substance and processes for the preparation thereof
05/29/2012US8188074 Biologically active methylene blue derivatives
05/23/2012EP2455083A1 Pharmaceutical composition for dermal use comprising calcipotriol and a corticosteroid
05/17/2012US20120121724 Film comprising therapeutic agents
05/15/2012CA2516581C Attenuated strains of vibrio cholerae with improved biological safety features in freeze dried form for oral vaccination
05/09/2012EP2450043A1 Pharmaceutical composition for dermal use to treat psoriasis, sebopsoriasis or seborrhoic dermatitis comprising a vitamin D and a corticosteroid
05/09/2012EP2100605B9 Bis(thio-hydrazide amide) compounds in combination with taxol for treating cancer
05/02/2012EP1415992B1 Diamine derivatives
05/01/2012CA2400559C Humanized antibodies that sequester .alpha..beta. peptide
04/2012
04/18/2012CN101579343B Low hygroscopic aripiprazole drug substance and processes for the preparation thereof
04/17/2012CA2516589C Hiv replication inhibiting pyrimidines and triazines
04/05/2012US20120082725 Composition Comprising Immunogenic Microparticles
03/2012
03/27/2012US8143261 Thiazolo (4,5-D) pyrimidine compounds
03/27/2012US8143239 Composition for inhalation
03/21/2012EP1320540B9 Peptidomimetic protease inhibitors
03/21/2012CN101130071B Vaccine
03/20/2012CA2405076C Dual molecules containing a peroxide derivative, synthesis and therapeutic applications thereof
03/15/2012US20120064034 Peptidomimetic protease inhibitors
03/13/2012CA2419607C Peptidomimetic protease inhibitors
03/07/2012CN101381339B Prodrugs of gaba analogs, compositions and uses thereof
03/06/2012CA2370697C Adjuvant composition comprising saponin and an immunostimulatory oligonucleotide
02/2012
02/29/2012CN101574347B Aripiprazole medicinal agent of low hygroscopicity and methods for its preparing
02/22/2012CN101574348B 低吸湿性阿立哌唑药物及其制备方法 Low hygroscopic aripiprazole drug and its preparation method
02/16/2012US20120041010 Pharmaceutical combination of (e)-7-[4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino]pyrimidin-5-yl] (3r,5s)-3,5-dihydroxyhept-6-enoic acid and candesartan
02/14/2012US8115027 NPY Y5 antagonist
02/14/2012US8114885 Chemical compounds
02/14/2012CA2463154C Heterocyclic compounds and methods of use
02/07/2012CA2460655C Combination of selected opioids with muscarine antagonists for treating urinary incontinence
01/2012
01/24/2012US8101650 Method for treating a immunology-related disease
01/24/2012CA2526578C Pyrazolo-quinazoline derivatives, process for their preparation and their use as kinase inhibitors
01/19/2012US20120016123 Low hygroscopic aripiprazole drug substance and processes for the preparation thereof
01/19/2012US20120016023 Combination of Selected Opioids with Muscarine Antagonists for Treating Urinary Incontinence
01/10/2012CA2419541C Interleukin-22 polypeptides, nucleic acids encoding the same and methods for the treatment of pancreatic disorders
01/10/2012CA2366314C Protein d from haemophilus influenzae as a carrier protein in combination vaccines
01/05/2012US20120000998 Low hygroscopic aripiprazole drug substance and processes for the preparation thereof
01/03/2012CA2499622C Sphingosine-1-phosphate receptor agonists in the treatment of demyelinating disorders
01/03/2012CA2486712C Method of treating diabetes
12/2011
12/22/2011US20110312990 Diamine Derivatives
12/14/2011EP1532122B1 11-beta-hydroxysteroid dehydrogenase 1 inhibitors useful for the treatment of diabetes, obesity and dyslipidemia
12/14/2011CN101434574B 低吸湿性阿立哌唑药物及其制备方法 Low hygroscopic aripiprazole drug and its preparation method
12/13/2011US8076361 Form of S-omeprazole
12/07/2011CN101434573B 低吸湿性阿立哌唑药物及其制备方法 Low hygroscopic aripiprazole drug and its preparation method
12/06/2011CA2380858C Inhibitors of aspartyl protease
11/2011
11/29/2011US8067396 Amino alcohol compounds or phosphonic acid derivatives thereof
11/29/2011CA2479786C Quinoline derivatives and their use as 5-ht6 ligands
11/23/2011EP1391451B1 2-iminopyrrolidine derivates
11/23/2011CN102250071A Pyrazole compounds useful as protein kinase inhibitors
11/22/2011US8063056 Anti-cancer cyclopenta [g]quinazonline compounds
11/09/2011EP2385039A1 2-Iminoisoindolinone derivatives as thrombin receptor antagonists
11/08/2011US8053410 Pegylated factor VII glycoforms
11/01/2011CA2473461C Amino alcohol derivative or phosphonic acid derivative and medicinal composition containing these
11/01/2011CA2458813C Anti-cancer cyclopenta[g]quinazoline compounds
10/2011
10/18/2011CA2466499C Use of a mixture of sodium hyaluronate and chondroitin sulfate for the treatment of osteoarthritis
10/13/2011US20110251171 Heterocyclic compounds and methods of use
10/06/2011US20110245165 Peptide agonists of glp-1 activity
10/05/2011EP2371839A1 Peptidomimetic protease inhibitors
09/2011
09/29/2011US20110237792 Quinoline derivatives and their use as 5-ht6 ligands
09/28/2011EP2368901A1 Peptidomimetic protease inhibitors
09/28/2011EP2368878A1 Peptidomimetic protease inhibitors
09/28/2011EP2368877A1 Chiral intermediates for the preparation of peptidomimetic protease inhibitors
09/28/2011CN101531631B Substituted pyridinones as modulators of p38 map kinase
09/13/2011US8017615 Low hygroscopic aripiprazole drug substance and processes for the preparation thereof
09/08/2011US20110217329 Vaccine
09/07/2011EP2100605B1 Bis(thio-hydrazide amide) compounds in combination with taxol for treating cancer
1 2 3 4 5 6 7 8 9 10 11 12 ... 32